Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE Study
Citation
Gurnell , M , Domingo , C , Rabe , K F , Menzies-Gow , A , Price , D , Brusselle , G , Wechsler , M E , Xia , C , Pandit-Abid , N , Gall , R , Jacob-Nara , J A , Rowe , P J , Deniz , Y & Siddiqui , S 2022 , ' Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE Study ' , EAACI HYBRID CONGRESS 2022 , Prague , Czech Republic , 1/07/22 - 3/07/22 . conference